cloudfront

Report Detail



Pharmaceuticals & HealthcareRestenosis - Pipeline Review, H2 2018

  • RnM2315574
  • |
  • 7 August, 2018
  • |
  • Global
  • |
  • 44 pages
  • |
  • Global Markets Direct
  • |
  • Pharmaceuticals & Healthcare

Restenosis - Pipeline Review, H2 2018

Table of Contents

    List of Tables

      List of Figures

        Introduction

          Global Markets Direct Report Coverage

            Restenosis - Overview

              Restenosis - Therapeutics Development

                Pipeline Overview

                  Pipeline by Companies

                    Pipeline by Universities/Institutes

                      Products under Development by Companies

                        Products under Development by Universities/Institutes

                          Restenosis - Therapeutics Assessment

                            Assessment by Target

                              Assessment by Mechanism of Action

                                Assessment by Route of Administration

                                  Assessment by Molecule Type

                                    Restenosis - Companies Involved in Therapeutics Development

                                      CytoTools AG

                                        XBiotech Inc

                                          Restenosis - Drug Profiles

                                            (connective tissue growth factor + insulin human) - Drug Profile

                                              Product Description

                                                Mechanism Of Action

                                                  R&D Progress

                                                    HMW-02Ak - Drug Profile

                                                      Product Description

                                                        Mechanism Of Action

                                                          R&D Progress

                                                            HMW-02Ap - Drug Profile

                                                              Product Description

                                                                Mechanism Of Action

                                                                  R&D Progress

                                                                    TW-01 - Drug Profile

                                                                      Product Description

                                                                        Mechanism Of Action

                                                                          R&D Progress

                                                                            Xilonix - Drug Profile

                                                                              Product Description

                                                                                Mechanism Of Action

                                                                                  R&D Progress

                                                                                    Restenosis - Dormant Projects

                                                                                      Restenosis - Discontinued Products

                                                                                        Restenosis - Product Development Milestones

                                                                                          Featured News & Press Releases

                                                                                            Jan 03, 2013: XBiotech Receives Fast Track Designation From FDA For True Human Monoclonal Antibody Therapy Targeting Inflammatory Cytokine IL-1a For Restenosis

                                                                                              Nov 20, 2012: XBiotech Reports Positive Phase II Interim Analysis Results Of MABp1 In Vascular Disease

                                                                                                Aug 18, 2011: XBiotech Announces Initiation Of Restenosis Clinical Trial In All Five US Sites

                                                                                                  Dec 22, 2010: XBiotech Files IND For CV-18C3 Monoclonal Antibody Therapy To Treat Peripheral Vascular Disease

                                                                                                    Appendix

                                                                                                      Methodology

                                                                                                        Coverage

                                                                                                          Secondary Research

                                                                                                            Primary Research

                                                                                                              Expert Panel Validation

                                                                                                                Contact Us

                                                                                                                  Disclaimer

                                                                                                                  Restenosis - Pipeline Review, H2 2018

                                                                                                                  Summary

                                                                                                                  Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Restenosis - Pipeline Review, H2 2018, provides an overview of the Restenosis (Cardiovascular) pipeline landscape.

                                                                                                                  Restenosis is re-narrowing of a blood vessel which leads to restricted blood flow. Symptoms include shortness of breath, difficulty walking and chest pain. Risk factors include increasing age, gender, family history or race and diabetes. Treatment includes surgery and thrombolytic therapy.

                                                                                                                  Report Highlights

                                                                                                                  Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Restenosis - Pipeline Review, H2 2018, provides comprehensive information on the therapeutics under development for Restenosis (Cardiovascular), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

                                                                                                                  The Restenosis (Cardiovascular) pipeline guide also reviews of key players involved in therapeutic development for Restenosis and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Phase II and Preclinical stages are 1 and 2 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 2 molecules, respectively.

                                                                                                                  Restenosis (Cardiovascular) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

                                                                                                                  Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

                                                                                                                  Scope

                                                                                                                  - The pipeline guide provides a snapshot of the global therapeutic landscape of Restenosis (Cardiovascular).
                                                                                                                  - The pipeline guide reviews pipeline therapeutics for Restenosis (Cardiovascular) by companies and universities/research institutes based on information derived from company and industry-specific sources.
                                                                                                                  - The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
                                                                                                                  - The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
                                                                                                                  - The pipeline guide reviews key companies involved in Restenosis (Cardiovascular) therapeutics and enlists all their major and minor projects.
                                                                                                                  - The pipeline guide evaluates Restenosis (Cardiovascular) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
                                                                                                                  - The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
                                                                                                                  - The pipeline guide reviews latest news related to pipeline therapeutics for Restenosis (Cardiovascular)

                                                                                                                  Reasons to buy

                                                                                                                  - Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
                                                                                                                  - Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
                                                                                                                  - Find and recognize significant and varied types of therapeutics under development for Restenosis (Cardiovascular).
                                                                                                                  - Classify potential new clients or partners in the target demographic.
                                                                                                                  - Develop tactical initiatives by understanding the focus areas of leading companies.
                                                                                                                  - Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.
                                                                                                                  - Formulate corrective measures for pipeline projects by understanding Restenosis (Cardiovascular) pipeline depth and focus of Indication therapeutics.
                                                                                                                  - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
                                                                                                                  - Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.




                                                                                                                  Summary:
                                                                                                                  Get latest Market Research Reports on Restenosis. Industry analysis & Market Report on Restenosis is a syndicated market report, published as Restenosis - Pipeline Review, H2 2018. It is complete Research Study and Industry Analysis of Restenosis market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


                                                                                                                  REPORT YOU MIGHT BE INTERESTED

                                                                                                                  Purchase this Report

                                                                                                                  $2,000.00
                                                                                                                  $4,000.00
                                                                                                                  $6,000.00
                                                                                                                  1,343.00
                                                                                                                  2,686.00
                                                                                                                  4,029.00
                                                                                                                  1,840.40
                                                                                                                  3,680.80
                                                                                                                  5,521.20
                                                                                                                  242,280.00
                                                                                                                  484,560.00
                                                                                                                  726,840.00
                                                                                                                  132,626.80
                                                                                                                  265,253.60
                                                                                                                  397,880.40
                                                                                                                  Add To Cart Credit card Logo

                                                                                                                  Related Reports


                                                                                                                  Reason to Buy

                                                                                                                  Request for Sample of this report